The independent investigative committee found that a routing mistake by a station master sent a passenger train onto the same ...
Pharmaceuticals announced that the European Medicines Agency’s, EMA, Committee for Medicinal Products for Human Use, CHMP, has ...
JAK inhibitor Rinvoq (upadacitinib) has been backed by the CHMP as a 15mg, once-daily treatment for adults with GCA, an ...
The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...
If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney disease with no currently approved treatments2-5 Phase ...
Neurotech International has received positive feedback from the European Medicines Agency (EMA) on the company’s Orphan ...
The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...
2d
GlobalData on MSNEMA approves Takeda’s Takhzyro pre-filled pen option for HAEThe EMA has granted approval for an additional 2 mL pre-filled pen option for Takeda’s Takhzyro, aimed at treating HAE.
Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...
Other companies use customer reference and patient data to improve operational agility as they launch and scale their first ...
With the European Medicines Agency identifying shortages in more than 30 critical medicines, the single market presents an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results